Basic Information
Cygnal Therapeutics, founded by Flagship Pioneering in 2017, is the first company to build a platform for drug development in the field of exoneural biology. Driven by their Exoneural Medicine Platform™, Cygnal Therapeutics is developing new drugs across multiple therapeutic areas including cancer and inflammatory diseases.
Cygnal Therapeutics
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2017
info@cygnaltx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios